| Rifampin | Approved Investigational | CYP3A7 | 1551 |
upregulated | Rifampin results in increased expression of CYP3A7 mRNA | 7q22.1 | |
| Rifampin | Approved Investigational | CYP7A1 | 1581 |
downregulated | Rifampin results in decreased expression of CYP7A1 mRNA | 8q12.1 | |
| Rifampin | Approved Investigational | DCAF5 | 8816 |
downregulated | Rifampin results in decreased expression of DCAF5 mRNA | 14q24.1 | |
| Rifampin | Approved Investigational | DCLRE1B | 64858 |
downregulated | Rifampin results in decreased expression of DCLRE1B mRNA | 1p13.2 | |
| Rifampin | Approved Investigational | DHCR24 | 1718 |
upregulated | [Rifampin results in increased activity of NR1I2 protein] which results in increased expression of DHCR24 mRNA | 1p32.3 | |
| Rifampin | Approved Investigational | DIO1 | 1733 |
upregulated | Rifampin results in increased expression of DIO1 mRNA | 1p32.3 | |
| Rifampin | Approved Investigational | DLX4 | 1748 |
downregulated | Rifampin results in decreased expression of DLX4 mRNA | 17q21.33 | |
| Rifampin | Approved Investigational | ELK1 | 2002 |
downregulated | Rifampin results in decreased expression of ELK1 mRNA | Xp11.23 | |
| Rifampin | Approved Investigational | EPHA1-AS1 | 285965 |
downregulated | Rifampin results in decreased expression of EPHA1-AS1 mRNA | 7q35 | |
| Rifampin | Approved Investigational | EPHX1 | 2052 |
upregulated | Rifampin results in increased expression of EPHX1 mRNA | 1q42.12 | |
| Rifampin | Approved Investigational | ETNPPL | 64850 |
upregulated | Rifampin results in increased expression of ETNPPL mRNA | 4q25 | |
| Rifampin | Approved Investigational | F13B | 2165 |
upregulated | Rifampin results in increased expression of F13B mRNA | 1q31.3 | |
| Rifampin | Approved Investigational | FAM200A | 221786 |
upregulated | Rifampin results in increased expression of FAM200A mRNA | 7q22.1 | |
| Rifampin | Approved Investigational | FAM230C | 26080 |
downregulated | Rifampin results in decreased expression of FAM230C mRNA | 13q11 | |
| Rifampin | Approved Investigational | FAM66D | 100132923 |
downregulated | Rifampin results in decreased expression of FAM66D mRNA | 8p23.1 | |
| Rifampin | Approved Investigational | FASLG | 356 |
downregulated | Rifampin results in decreased expression of FASLG mRNA | 1q24.3 | |
| Rifampin | Approved Investigational | FGF19 | 9965 |
upregulated | [Rifampin binds to and results in increased activity of NR1I2 protein] which results in increased expression of FGF19 mRNA | 11q13.3 | |
| Rifampin | Approved Investigational | FGF19 | 9965 |
upregulated | Rifampin results in increased expression of FGF19 mRNA | 11q13.3 | |
| Rifampin | Approved Investigational | FOXP1 | 27086 |
upregulated | Rifampin results in increased expression of FOXP1 mRNA | 3p13 | |
| Rifampin | Approved Investigational | FUT1 | 2523 |
downregulated | Rifampin results in decreased expression of FUT1 mRNA | 19q13.33 | |
| Rifampin | Approved Investigational | GCOM1 | 145781 |
downregulated | Rifampin results in decreased expression of GCOM1 mRNA | 15q21.3 | |
| Rifampin | Approved Investigational | GLIS2 | 84662 |
upregulated | Rifampin results in increased expression of GLIS2 mRNA | 16p13.3 | |
| Rifampin | Approved Investigational | GNAL | 2774 |
downregulated | Rifampin results in decreased expression of GNAL mRNA | 18p11.21 | |
| Rifampin | Approved Investigational | GRIA1 | 2890 |
downregulated | Rifampin results in decreased expression of GRIA1 mRNA | 5q33.2 | |
| Rifampin | Approved Investigational | GSTA1 | 2938 |
upregulated | Rifampin results in increased expression of GSTA1 mRNA | 6p12.2 | |